Premium
Etomidate in urological outpatient anaesthesia
Author(s) -
LEES N.W.,
HENDRY J.G.B.
Publication year - 1977
Publication title -
anaesthesia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/j.1365-2044.1977.tb10016.x
Subject(s) - medicine , etomidate , premedication , anesthesia , atropine , incidence (geometry) , outpatient surgery , propanidid , general anaesthesia , heart rate , outpatient procedure , surgery , blood pressure , ambulatory , propofol , physics , optics
Induction of anaesthesia with the new short acting agent etomidate has been studied in 200 patients undergoing urological outpatient procedures. These patients exhibited a similar pattern of recovery to those receiving 7 mg/kg propanidid but had greater cardiac and respiratory stability. However, there was a 25% incidence of pain which was reduced to 13-9% by increasing the rate of injection from 30 to 15 seconds. The incidence of involuntary movements was 29-7% which was reduced to 15% by the faster rate of injection. The omission of atropine premedication did not affect cardiac stability. Etomidate appears to have many desirable features as an induction agent except for a high incidence of pain on injection which is reduced by rapid injection.